001 | Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) | Claims, Electronic Health Record, Cms Web Interface, Registry |
005 | Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) | Electronic Health Record, Registry |
006 | Coronary Artery Disease (CAD): Antiplatelet Therapy | Registry |
007 | Coronary Artery Disease (CAD): Beta-Blocker Therapy - Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) | Electronic Health Record, Registry |
008 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) | Electronic Health Record, Registry |
009 | Anti-Depressant Medication Management | Electronic Health Record |
012 | Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation | Claims, Electronic Health Record, Registry |
014 | Age-Related Macular Degeneration (AMD): Dilated Macular Examination | Claims, Registry |
019 | Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care | Claims, Electronic Health Record, Registry |
021 | Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second-Generation Cephalosporin | Claims, Registry |
023 | Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) | Claims, Registry |
024 | Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older | Claims, Registry |
039 | Screening for Osteoporosis for Women Aged 65-85 Years of Age | Claims, Registry |
044 | Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery | Registry |
046 | Medication Reconciliation Post-Discharge | Claims, Registry |
047 | Advance Care Plan | Claims, Registry |
048 | Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older | Claims, Registry |
050 | Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older | Claims, Registry |
051 | Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation | Claims, Registry |
052 | Chronic Obstructive Pulmonary Disease (COPD): Long-Acting Inhaled Bronchodilator Therapy | Claims, Registry |
065 | Appropriate Treatment for Children with Upper Respiratory Infection (URI) | Electronic Health Record, Registry |
066 | Appropriate Testing for Children with Pharyngitis | Electronic Health Record, Registry |
067 | Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow | Registry |
068 | Hematology: Myelodysplastic Syndrome (MDS): Documentation of Iron Stores in Patients Receiving Erythropoietin Therapy | Registry |
069 | Hematology: Multiple Myeloma: Treatment with Bisphosphonates | Registry |
070 | Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow Cytometry | Registry |
076 | Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections | Claims, Registry |
091 | Acute Otitis Externa (AOE): Topical Therapy | Claims, Registry |
093 | Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy - Avoidance of Inappropriate Use | Claims, Registry |
102 | Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients | Electronic Health Record, Registry |
104 | Prostate Cancer: Combination Androgen Deprivation Therapy for High Risk or Very High Risk Prostate Cancer | Registry |
107 | Adult Major Depressive Disorder (MDD): Suicide Risk Assessment | Electronic Health Record |
109 | Osteoarthritis (OA): Function and Pain Assessment | Claims, Registry |
110 | Preventive Care and Screening: Influenza Immunization | Claims, Electronic Health Record, Cms Web Interface, Registry |
111 | Pneumococcal Vaccination Status for Older Adults | Claims, Electronic Health Record, Registry |
112 | Breast Cancer Screening | Claims, Electronic Health Record, Cms Web Interface, Registry |
113 | Colorectal Cancer Screening | Claims, Electronic Health Record, Cms Web Interface, Registry |
116 | Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis | Registry |
117 | Diabetes: Eye Exam | Claims, Electronic Health Record, Registry |
118 | Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%) | Registry |
119 | Diabetes: Medical Attention for Nephropathy | Electronic Health Record, Registry |
126 | Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy - Neurological Evaluation | Registry |
127 | Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention - Evaluation of Footwear | Registry |
128 | Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan | Claims, Electronic Health Record, Registry |
130 | Documentation of Current Medications in the Medical Record | Claims, Electronic Health Record, Registry |
131 | Pain Assessment and Follow-Up | Claims, Registry |
134 | Preventive Care and Screening: Screening for Depression and Follow-Up Plan | Claims, Electronic Health Record, Cms Web Interface, Registry |
137 | Melanoma: Continuity of Care - Recall System | Registry |
138 | Melanoma: Coordination of Care | Registry |
141 | Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care | Claims, Registry |
143 | Oncology: Medical and Radiation - Pain Intensity Quantified | Electronic Health Record, Registry |
144 | Oncology: Medical and Radiation - Plan of Care for Moderate to Severe Pain | Registry |
145 | Radiology: Exposure Dose Indices or Exposure Time and Number of Images Reported for Procedures Using Fluoroscopy | Claims, Registry |
146 | Radiology: Inappropriate Use of "Probably Benign" Assessment Category in Screening Mammograms | Claims, Registry |
147 | Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy | Claims, Registry |
154 | Falls: Risk Assessment | Claims, Registry |
155 | Falls: Plan of Care | Claims, Registry |
160 | HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis | Electronic Health Record |
164 | Coronary Artery Bypass Graft (CABG): Prolonged Intubation | Registry |
165 | Coronary Artery Bypass Graft (CABG): Deep Sternal Wound Infection Rate | Registry |
166 | Coronary Artery Bypass Graft (CABG): Stroke | Registry |
167 | Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure | Registry |
168 | Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration | Registry |
176 | Rheumatoid Arthritis (RA): Tuberculosis Screening | Registry |
177 | Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity | Registry |
178 | Rheumatoid Arthritis (RA): Functional Status Assessment | Registry |
179 | Rheumatoid Arthritis (RA): Assessment and Classification of Disease Prognosis | Registry |
180 | Rheumatoid Arthritis (RA): Glucocorticoid Management | Registry |
181 | Elder Maltreatment Screen and Follow-Up Plan | Claims, Registry |
182 | Functional Outcome Assessment | Claims, Registry |
185 | Colonoscopy Interval for Patients with a History of Adenomatous Polyps
- Avoidance of Inappropriate Use | Registry |
187 | Stroke and Stroke Rehabilitation: Thrombolytic Therapy | Registry |
191 | Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery | Electronic Health Record, Registry |
192 | Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures | Electronic Health Record, Registry |
195 | Radiology: Stenosis Measurement in Carotid Imaging Reports | Claims, Registry |
205 | HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis | Registry |
217 | Functional Status Change for Patients with Knee Impairments | Registry |
218 | Functional Status Change for Patients with Hip Impairments | Registry |
219 | Functional Status Change for Patients with Lower Leg, Foot or Ankle Impairments | Registry |
220 | Functional Status Change for Patients with Low Back Impairments | Registry |
221 | Functional Status Change for Patients with Shoulder Impairments | Registry |
222 | Functional Status Change for Patients with Elbow, Wrist or Hand Impairments | Registry |
223 | Functional Status Change for Patients with General Orthopedic Impairments | Registry |
225 | Radiology: Reminder System for Screening Mammograms | Claims, Registry |
226 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | Claims, Electronic Health Record, Cms Web Interface, Registry |
236 | Controlling High Blood Pressure | Claims, Electronic Health Record, Cms Web Interface, Registry |
238 | Use of High-Risk Medications in the Elderly | Electronic Health Record, Registry |
239 | Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents | Electronic Health Record |
240 | Childhood Immunization Status | Electronic Health Record |
243 | Cardiac Rehabilitation Patient Referral from an Outpatient Setting | Registry |
249 | Barrett's Esophagus | Claims, Registry |
250 | Radical Prostatectomy Pathology Reporting | Claims, Registry |
254 | Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain | Claims, Registry |
255 | Rh Immunoglobulin (Rhogam) for Rh-Negative Pregnant Women at Risk of Fetal Blood Exposure | Claims, Registry |
258 | Rate of Open Repair of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7) | Registry |
259 | Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post Operative Day #2) | Registry |
260 | Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) | Registry |
261 | Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness | Claims, Registry |
262 | Image Confirmation of Successful Excision of Image-Localized Breast Lesion | Registry |
264 | Sentinel Lymph Node Biopsy for Invasive Breast Cancer | Registry |
265 | Biopsy Follow-Up | Registry |
268 | Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy | Claims, Registry |
271 | Inflammatory Bowel Disease (IBD): Preventive Care: Corticosteroid Related Iatrogenic Injury - Bone Loss Assessment | Registry |
275 | Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy | Registry |
277 | Sleep Apnea: Severity Assessment at Initial Diagnosis | Registry |
279 | Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy | Registry |
281 | Dementia: Cognitive Assessment | Electronic Health Record |
282 | Dementia: Functional Status Assessment | Registry |
283 | Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management | Registry |
286 | Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia | Registry |
288 | Dementia: Education and Support of Caregivers for Patients with Dementia | Registry |
290 | Parkinson's Disease: Psychiatric Symptoms Assessment for Patients with Parkinson's Disease | Registry |
291 | Parkinson's Disease: Cognitive Impairment or Dysfunction Assessment for Patients with Parkinson's Disease | Registry |
293 | Parkinson's Disease: Rehabilitative Therapy Options | Registry |
303 | Cataracts: Improvement in Patient's Visual Function within 90 Days Following Cataract Surgery | Registry |
304 | Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery | Registry |
305 | Initiation and Engagement of Alcohol and Other Drug Dependence Treatment | Electronic Health Record |
309 | Cervical Cancer Screening | Electronic Health Record |
310 | Chlamydia Screening for Women | Electronic Health Record |
317 | Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented | Claims, Electronic Health Record, Registry |
318 | Falls: Screening for Future Fall Risk | Electronic Health Record, Cms Web Interface |
320 | Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients | Claims, Registry |
321 | CAHPS for MIPS Group Survey | Certified Survey Vendor |
322 | Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery Patients | Registry |
323 | Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI) | Registry |
324 | Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk Patients | Registry |
325 | Adult Major Depressive Disorder (MDD): Coordination of Care of Patients with Specific Comorbid Conditions | Registry |
326 | Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy | Claims, Registry |
328 | Pediatric Kidney Disease: ESRD Patients Receiving Dialysis: Hemoglobin Level < 10g/dL | Registry |
329 | Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis | Registry |
330 | Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days | Registry |
331 | Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse) | Registry |
332 | Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use) | Registry |
333 | Adult Sinusitis: Computerized Tomography (CT) for Acute Sinusitis (Overuse) | Registry |
335 | Maternity Care: Elective Delivery or Early Induction Without Medical Indication at >= 37 and < 39 Weeks (Overuse) | Registry |
336 | Maternity Care: Post-Partum Follow-Up and Care Coordination | Registry |
337 | Psoriasis: Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis on a Biological Immune Response Modifier | Registry |
338 | HIV Viral Load Suppression | Registry |
340 | HIV Medical Visit Frequency | Registry |
342 | Pain Brought Under Control Within 48 Hours | Registry |
343 | Screening Colonoscopy Adenoma Detection Rate | Registry |
344 | Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2) | Registry |
345 | Rate of Asymptomatic Patients Undergoing Carotid Artery Stenting (CAS) Who Are Stroke Free or Discharged Alive | Registry |
346 | Rate of Asymptomatic Patients Undergoing Carotid Endarterectomy (CEA) Who Are Stroke Free or Discharged Alive | Registry |
347 | Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) Who Are Discharged Alive | Registry |
348 | HRS-3: Implantable Cardioverter-Defibrillator (ICD) Complications Rate | Registry |
350 | Total Knee Replacement: Shared Decision-Making: Trial of Conservative (Non-surgical) Therapy | Registry |
351 | Total Knee Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation | Registry |
352 | Total Knee Replacement: Preoperative Antibiotic Infusion with Proximal Tourniquet | Registry |
353 | Total Knee Replacement: Identification of Implanted Prosthesis in Operative Report | Registry |
354 | Anastomotic Leak Intervention | Registry |
355 | Unplanned Reoperation within the 30 Day Postoperative Period | Registry |
356 | Unplanned Hospital Readmission within 30 Days of Principal Procedure | Registry |
357 | Surgical Site Infection (SSI) | Registry |
358 | Patient-Centered Surgical Risk Assessment and Communication | Registry |
360 | Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine Studies | Registry |
361 | Optimizing Patient Exposure to Ionizing Radiation: Reporting to a Radiation Dose Index Registry | Registry |
362 | Optimizing Patient Exposure to Ionizing Radiation: Computed Tomography (CT) Images Available for Patient Follow-up and Comparison Purposes | Registry |
364 | Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines | Registry |
366 | Follow-Up Care for Children Prescribed ADHD Medication (ADD) | Electronic Health Record |
370 | Depression Remission at Twelve Months | Electronic Health Record, Cms Web Interface, Registry |
371 | Depression Utilization of the PHQ-9 Tool | Electronic Health Record |
372 | Maternal Depression Screening | Electronic Health Record |
374 | Closing the Referral Loop: Receipt of Specialist Report | Electronic Health Record, Registry |
375 | Functional Status Assessment for Total Knee Replacement | Electronic Health Record |
376 | Functional Status Assessment for Total Hip Replacement | Electronic Health Record |
377 | Functional Status Assessments for Congestive Heart Failure | Electronic Health Record |
378 | Children Who Have Dental Decay or Cavities | Electronic Health Record |
379 | Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists | Electronic Health Record |
382 | Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment | Electronic Health Record |
383 | Adherence to Antipsychotic Medications For Individuals with Schizophrenia | Registry |
384 | Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of Surgery | Registry |
385 | Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of Surgery | Registry |
386 | Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences | Registry |
387 | Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users | Registry |
388 | Cataract Surgery with Intra-Operative Complications (Unplanned Rupture of Posterior Capsule Requiring Unplanned Vitrectomy) | Registry |
389 | Cataract Surgery: Difference Between Planned and Final Refraction | Registry |
390 | Hepatitis C: Discussion and Shared Decision Making Surrounding Treatment Options | Registry |
391 | Follow-Up After Hospitalization for Mental Illness (FUH) | Registry |
392 | HRS-12: Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation | Registry |
393 | HRS-9: Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision | Registry |
394 | Immunizations for Adolescents | Registry |
395 | Lung Cancer Reporting (Biopsy/Cytology Specimens) | Claims, Registry |
396 | Lung Cancer Reporting (Resection Specimens) | Claims, Registry |
397 | Melanoma Reporting | Claims, Registry |
398 | Optimal Asthma Control | Registry |
400 | One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk | Registry |
401 | Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis | Registry |
402 | Tobacco Use and Help with Quitting Among Adolescents | Registry |
403 | Adult Kidney Disease: Referral to Hospice | Registry |
404 | Anesthesiology Smoking Abstinence | Registry |
405 | Appropriate Follow-up Imaging for Incidental Abdominal Lesions | Claims, Registry |
406 | Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients | Claims, Registry |
407 | Appropriate Treatment of Methicillin-Susceptible Staphylococcus Aureus (MSSA) Bacteremia | Claims, Registry |
408 | Opioid Therapy Follow-up Evaluation | Registry |
409 | Clinical Outcome Post Endovascular Stroke Treatment | Registry |
410 | Psoriasis: Clinical Response to Systemic Medications | Registry |
411 | Depression Remission at Six Months | Registry |
412 | Documentation of Signed Opioid Treatment Agreement | Registry |
413 | Door to Puncture Time for Endovascular Stroke Treatment | Registry |
414 | Evaluation or Interview for Risk of Opioid Misuse | Registry |
415 | Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older | Claims, Registry |
416 | Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years | Claims, Registry |
417 | Rate of Open Repair of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) Where Patients Are Discharged Alive | Registry |
418 | Osteoporosis Management in Women Who Had a Fracture | Claims, Registry |
419 | Overuse of Imaging for the Evaluation of Primary Headache | Claims, Registry |
420 | Varicose Vein Treatment with Saphenous Ablation: Outcome Survey | Registry |
421 | Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for Removal | Registry |
422 | Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury | Claims, Registry |
424 | Perioperative Temperature Management | Registry |
425 | Photodocumentation of Cecal Intubation | Claims, Registry |
428 | Pelvic Organ Prolapse: Preoperative Assessment of Occult Stress Urinary Incontinence | Registry |
429 | Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy | Claims, Registry |
430 | Prevention of Post-Operative Nausea and Vomiting (PONV) - Combination Therapy | Registry |
431 | Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling | Registry |
432 | Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair | Registry |
433 | Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair | Registry |
434 | Proportion of Patients Sustaining a Ureter Injury at the Time of Pelvic Organ Prolapse Repair | Registry |
435 | Quality of Life Assessment For Patients With Primary Headache Disorders | Claims, Registry |
436 | Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques | Claims, Registry |
437 | Rate of Surgical Conversion from Lower Extremity Endovascular Revascularization Procedure | Claims, Registry |
438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | Electronic Health Record, Cms Web Interface, Registry |
439 | Age Appropriate Screening Colonoscopy | Registry |
440 | Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time - Pathologist to Clinician | Registry |
441 | Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control) | Registry |
442 | Persistence of Beta-Blocker Treatment After a Heart Attack | Registry |
443 | Non-Recommended Cervical Cancer Screening in Adolescent Females | Registry |
444 | Medication Management for People with Asthma | Registry |
445 | Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG) | Registry |
446 | Operative Mortality Stratified by the Five STS-EACTS Mortality Categories | Registry |
448 | Appropriate Workup Prior to Endometrial Ablation | Registry |
449 | HER2 Negative or Undocumented Breast Cancer Patients Spared Treatment with HER2-Targeted Therapies | Registry |
450 | Trastuzumab Received By Patients With AJCC Stage I (T1c) - III And HER2 Positive Breast Cancer Receiving Adjuvant Chemotherapy | Registry |
451 | RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy | Registry |
452 | Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies | Registry |
453 | Percentage of Patients Who Died from Cancer Receiving Chemotherapy in the Last 14 Days of Life (lower score - better) | Registry |
454 | Percentage of Patients who Died from Cancer with More than One Emergency Department Visit in the Last 30 Days of Life (lower score - better) | Registry |
455 | Percentage of Patients Who Died from Cancer Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of Life (lower score - better) | Registry |
456 | Percentage of Patients Who Died From Cancer Not Admitted To Hospice (lower score - better) | Registry |
457 | Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score - better) | Registry |
458 | All-cause Hospital Readmission | Administrative Claims |
459 | Average Change in Back Pain Following Lumbar Discectomy/Laminotomy | Registry |
460 | Average Change in Back Pain Following Lumbar Fusion | Registry |
461 | Average Change in Leg Pain Following Lumbar Discectomy and/or Laminotomy | Registry |
462 | Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy | Electronic Health Record |
463 | Prevention of Post-Operative Vomiting (POV) - Combination Therapy (Pediatrics) | Registry |
464 | Otitis Media with Effusion: Systemic Antimicrobials - Avoidance of Inappropriate Use | Registry |
465 | Uterine Artery Embolization Technique: Documentation of Angigraphic Endpoints and Interrogation of Ovarian Arteries | Registry |
467 | Developmental Screening in the First Three Years of Life | Registry |
468 | Continuity of Pharmacotherapy for Opioid Use Disorder (OUD) | Registry |
469 | Average Change in Functional Status Following Lumbar Fusion Surgery | Registry |
470 | Average Change In Functional Status Following Total Knee Replacement Surgery | Registry |
471 | Average Change in Functional Status Following Lumbar Discectomy/Laminotomy Surgery | Registry |
472 | Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture | Electronic Health Record |
473 | Average Change in Leg Pain Following Lumbar Fusion Surgery | Registry |
474 | Zoster (Shingles) Vaccination | Registry |
475 | HIV Screening | Electronic Health Record |
ACO321 | CAHPS for ACOs Group Survey | Certified Survey Vendor |
PI_PPHI_1 | Security Risk Analysis | |
PI_ONCDIR_1 | ONC Direct Review Attestation | |
PI_INFBLO_1 | Prevention of Information Blocking Attestation | |
PI_ONCACB_1 | ONC-ACB Surveillance Attestation | |
PI_EP_1 | e-Prescribing | |
PI_LVPP_1 | e-Prescribing Exclusion | |
PI_EP_2 | Query of the Prescription Drug Monitoring Program (PDMP) | |
PI_EP_3 | Verify Opioid Treatment Agreement | |
PI_HIE_1 | Support Electronic Referral Loops By Sending Health Information | |
PI_LVOTC_1 | Support Electronic Referral Loops By Sending Health Information Exclusion | |
PI_HIE_4 | Support Electronic Referral Loops By Receiving and Incorporating Health Information | |
PI_LVITC_2 | Support Electronic Referral Loops By Receiving and Incorporating Health Information Exclusion | |
PI_CUITC_1 | Support Electronic Referral Loops By Receiving and Incorporating Health Information Exclusion | |
PI_PEA_1 | Provide Patients Electronic Access to Their Health Information | |
PI_PHCDRR_2 | Syndromic Surveillance Reporting | |
PI_PHCDRR_2_MULTI | Syndromic Surveillance Reporting for Multiple Registry Engagement | |
PI_PHCDRR_2_EX_1 | Syndromic Surveillance Reporting Exclusion | |
PI_PHCDRR_2_EX_2 | Syndromic Surveillance Reporting Exclusion | |
PI_PHCDRR_2_EX_3 | Syndromic Surveillance Reporting Exclusion | |
PI_PHCDRR_1 | Immunization Registry Reporting | |
PI_PHCDRR_1_MULTI | Immunization Registry Reporting for Multiple Registry Engagement | |
PI_PHCDRR_1_EX_1 | Immunization Registry Reporting Exclusion | |
PI_PHCDRR_1_EX_2 | Immunization Registry Reporting Exclusion | |
PI_PHCDRR_1_EX_3 | Immunization Registry Reporting Exclusion | |
PI_PHCDRR_3 | Electronic Case Reporting | |
PI_PHCDRR_3_MULTI | Electronic Case Reporting for Multiple Registry Engagement | |
PI_PHCDRR_3_EX_1 | Electronic Case Reporting Exclusion | |
PI_PHCDRR_3_EX_2 | Electronic Case Reporting Exclusion | |
PI_PHCDRR_3_EX_3 | Electronic Case Reporting Exclusion | |
PI_PHCDRR_4 | Public Health Registry Reporting | |
PI_PHCDRR_4_MULTI | Public Health Registry Reporting for Multiple Registry Engagement | |
PI_PHCDRR_4_EX_1 | Public Health Registry Reporting Exclusion | |
PI_PHCDRR_4_EX_2 | Public Health Registry Reporting Exclusion | |
PI_PHCDRR_4_EX_3 | Public Health Registry Reporting Exclusion | |
PI_PHCDRR_5 | Clinical Data Registry Reporting | |
PI_PHCDRR_5_MULTI | Clinical Data Registry Reporting for Multiple Registry Engagement | |
PI_PHCDRR_5_EX_1 | Clinical Data Registry Reporting Exclusion | |
PI_PHCDRR_5_EX_2 | Clinical Data Registry Reporting Exclusion | |
PI_PHCDRR_5_EX_3 | Clinical Data Registry Reporting Exclusion | |
CAHPS_1 | CAHPS for MIPS SSM: Getting Timely Care, Appointments, and Information | Certified Survey Vendor |
CAHPS_ACO_1 | CAHPS for ACO SSM: Getting Timely Care, Appointments, and Information | Certified Survey Vendor |
CAHPS_2 | CAHPS for MIPS SSM: How Well Providers Communicate | Certified Survey Vendor |
CAHPS_ACO_2 | CAHPS for ACO SSM: How Well Providers Communicate | Certified Survey Vendor |
CAHPS_3 | CAHPS for MIPS SSM: Patient’s Rating of Provider | Certified Survey Vendor |
CAHPS_ACO_3 | CAHPS for ACO SSM: Patient’s Rating of Provider | Certified Survey Vendor |
CAHPS_4 | CAHPS for MIPS SSM: Access to Specialists | Certified Survey Vendor |
CAHPS_ACO_4 | CAHPS for ACO SSM: Access to Specialists | Certified Survey Vendor |
CAHPS_5 | CAHPS for MIPS SSM: Health Promotion and Education | Certified Survey Vendor |
CAHPS_ACO_5 | CAHPS for ACO SSM: Health Promotion and Education | Certified Survey Vendor |
CAHPS_6 | CAHPS for MIPS SSM: Shared Decision Making | Certified Survey Vendor |
CAHPS_ACO_6 | CAHPS for ACO SSM: Shared Decision Making | Certified Survey Vendor |
CAHPS_7 | CAHPS for MIPS SSM: Health Status and Functional Status | Certified Survey Vendor |
CAHPS_ACO_7 | CAHPS for ACO SSM: Health Status and Functional Status | Certified Survey Vendor |
CAHPS_8 | CAHPS for MIPS SSM: Care Coordination | Certified Survey Vendor |
CAHPS_ACO_46 | CAHPS for ACO SSM: Care Coordination | Certified Survey Vendor |
CAHPS_9 | CAHPS for MIPS SSM: Courteous and Helpful Office Staff | Certified Survey Vendor |
CAHPS_ACO_45 | CAHPS for ACO SSM: Courteous and Helpful Office Staff | Certified Survey Vendor |
CAHPS_11 | CAHPS for MIPS SSM: Stewardship of Patient Resources | Certified Survey Vendor |
CAHPS_ACO_34 | CAHPS for ACO SSM: Stewardship of Patient Resources | Certified Survey Vendor |
IA_EPA_1 | Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record | |
IA_EPA_2 | Use of telehealth services that expand practice access | |
IA_EPA_3 | Collection and use of patient experience and satisfaction data on access | |
IA_EPA_4 | Additional improvements in access as a result of QIN/QIO TA | |
IA_EPA_5 | Participation in User Testing of the Quality Payment Program Website (https://qpp.cms.gov/) | |
IA_PM_1 | Participation in Systematic Anticoagulation Program | |
IA_PM_2 | Anticoagulant Management Improvements | |
IA_PM_3 | RHC, IHS or FQHC quality improvement activities | |
IA_PM_4 | Glycemic management services | |
IA_PM_5 | Engagement of community for health status improvement | |
IA_PM_6 | Use of toolsets or other resources to close healthcare disparities across communities | |
IA_PM_7 | Use of QCDR for feedback reports that incorporate population health | |
IA_PM_10 | Use of QCDR data for quality improvement such as comparative analysis reports across patient populations | |
IA_PM_11 | Regular Review Practices in Place on Targeted Patient Population Needs | |
IA_PM_12 | Population empanelment | |
IA_PM_13 | Chronic Care and Preventative Care Management for Empaneled Patients | |
IA_PM_14 | Implementation of methodologies for improvements in longitudinal care management for high risk patients | |
IA_PM_15 | Implementation of episodic care management practice improvements | |
IA_PM_16 | Implementation of medication management practice improvements | |
IA_PM_17 | Participation in Population Health Research | |
IA_PM_18 | Provide Clinical-Community Linkages | |
IA_PM_19 | Glycemic Screening Services | |
IA_PM_20 | Glycemic Referring Services | |
IA_PM_21 | Advance Care Planning | |
IA_CC_1 | Implementation of Use of Specialist Reports Back to Referring Clinician or Group to Close Referral Loop | |
IA_CC_2 | Implementation of improvements that contribute to more timely communication of test results | |
IA_CC_3 | Implementation of additional activity as a result of TA for improving care coordination | |
IA_CC_4 | TCPI Participation | |
IA_CC_5 | CMS partner in Patients Hospital Engagement Network | |
IA_CC_6 | Use of QCDR to promote standard practices, tools and processes in practice for improvement in care coordination | |
IA_CC_7 | Regular training in care coordination | |
IA_CC_8 | Implementation of documentation improvements for practice/process improvements | |
IA_CC_9 | Implementation of practices/processes for developing regular individual care plans | |
IA_CC_10 | Care transition documentation practice improvements | |
IA_CC_11 | Care transition standard operational improvements | |
IA_CC_12 | Care coordination agreements that promote improvements in patient tracking across settings | |
IA_CC_13 | Practice Improvements for Bilateral Exchange of Patient Information | |
IA_CC_14 | Practice Improvements that Engage Community Resources to Support Patient Health Goals | |
IA_CC_15 | PSH Care Coordination | |
IA_CC_16 | Primary Care Physician and Behavioral Health Bilateral Electronic Exchange of Information for Shared Patients | |
IA_CC_17 | Patient Navigator Program | |
IA_CC_18 | Relationship-Centered Communication | |
IA_BE_1 | Use of certified EHR to capture patient reported outcomes | |
IA_BE_2 | Use of QCDR to support clinical decision making | |
IA_BE_3 | Engagement with QIN-QIO to implement self-management training programs | |
IA_BE_4 | Engagement of patients through implementation of improvements in patient portal | |
IA_BE_5 | Enhancements/regular updates to practice websites/tools that also include considerations for patients with cognitive disabilities | |
IA_BE_6 | Collection and follow-up on patient experience and satisfaction data on beneficiary engagement | |
IA_BE_7 | Participation in a QCDR, that promotes use of patient engagement tools. | |
IA_BE_8 | Participation in a QCDR, that promotes collaborative learning network opportunities that are interactive. | |
IA_BE_9 | Use of QCDR patient experience data to inform and advance improvements in beneficiary engagement. | |
IA_BE_10 | Participation in a QCDR, that promotes implementation of patient self-action plans. | |
IA_BE_11 | Participation in a QCDR, that promotes use of processes and tools that engage patients for adherence to treatment plan. | |
IA_BE_12 | Use evidence-based decision aids to support shared decision-making. | |
IA_BE_13 | Regularly assess the patient experience of care through surveys, advisory councils and/or other mechanisms. | |
IA_BE_14 | Engage Patients and Families to Guide Improvement in the System of Care | |
IA_BE_15 | Engagement of Patients, Family, and Caregivers in Developing a Plan of Care | |
IA_BE_16 | Evidenced-based techniques to promote self-management into usual care | |
IA_BE_17 | Use of tools to assist patient self-management | |
IA_BE_18 | Provide peer-led support for self-management. | |
IA_BE_19 | Use group visits for common chronic conditions (e.g., diabetes). | |
IA_BE_20 | Implementation of condition-specific chronic disease self-management support programs | |
IA_BE_21 | Improved Practices that Disseminate Appropriate Self-Management Materials | |
IA_BE_22 | Improved Practices that Engage Patients Pre-Visit | |
IA_BE_23 | Integration of patient coaching practices between visits | |
IA_BE_24 | Financial Navigation Program | |
IA_PSPA_1 | Participation in an AHRQ-listed patient safety organization. | |
IA_PSPA_2 | Participation in MOC Part IV | |
IA_PSPA_3 | Participate in IHI Training/Forum Event; National Academy of Medicine, AHRQ Team STEPPS® or Other Similar Activity | |
IA_PSPA_4 | Administration of the AHRQ Survey of Patient Safety Culture | |
IA_PSPA_5 | Annual registration in the Prescription Drug Monitoring Program | |
IA_PSPA_6 | Consultation of the Prescription Drug Monitoring Program | |
IA_PSPA_7 | Use of QCDR data for ongoing practice assessment and improvements | |
IA_PSPA_8 | Use of Patient Safety Tools | |
IA_PSPA_9 | Completion of the AMA STEPS Forward program | |
IA_PSPA_10 | Completion of training and receipt of approved waiver for provision opioid medication-assisted treatments | |
IA_PSPA_11 | Participation in CAHPS or other supplemental questionnaire | |
IA_PSPA_12 | Participation in private payer CPIA | |
IA_PSPA_13 | Participation in Joint Commission Evaluation Initiative | |
IA_PSPA_14 | Participation in Quality Improvement Initiatives | |
IA_PSPA_15 | Implementation of an ASP | |
IA_PSPA_16 | Use of decision support and standardized treatment protocols | |
IA_PSPA_17 | Implementation of analytic capabilities to manage total cost of care for practice population | |
IA_PSPA_18 | Measurement and Improvement at the Practice and Panel Level | |
IA_PSPA_19 | Implementation of formal quality improvement methods, practice changes, or other practice improvement processes | |
IA_PSPA_20 | Leadership engagement in regular guidance and demonstrated commitment for implementing practice improvement changes | |
IA_PSPA_21 | Implementation of fall screening and assessment programs | |
IA_PSPA_22 | CDC Training on CDC's Guideline for Prescribing Opioids for Chronic Pain | |
IA_PSPA_23 | Completion of CDC Training on Antibiotic Stewardship | |
IA_PSPA_24 | Initiate CDC Training on Antibiotic Stewardship | |
IA_PSPA_25 | Cost Display for Laboratory and Radiographic Orders | |
IA_PSPA_26 | Communication of Unscheduled Visit for Adverse Drug Event and Nature of Event | |
IA_PSPA_27 | Invasive Procedure or Surgery Anticoagulation Medication Management | |
IA_PSPA_28 | Completion of an Accredited Safety or Quality Improvement Program | |
IA_PSPA_29 | Consulting AUC Using Clinical Decision Support when Ordering Advanced | |
IA_PSPA_30 | PCI Bleeding Campaign | |
IA_PSPA_31 | Patient Medication Risk Education | |
IA_PSPA_32 | Use of CDC Guideline for Clinical Decision Support to Prescribe Opioids for Chronic Pain via Clinical Decision Support | |
IA_AHE_1 | Engagement of New Medicaid Patients and Follow-up | |
IA_AHE_2 | Leveraging a QCDR to standardize processes for screening | |
IA_AHE_3 | Promote Use of Patient-Reported Outcome Tools | |
IA_AHE_4 | Leveraging a QCDR for use of standard questionnaires | |
IA_AHE_5 | MIPS Eligible Clinician Leadership in Clinical Trials or CBPR | |
IA_AHE_6 | Provide Education Opportunities for New Clinicians | |
IA_AHE_7 | Comprehensive Eye Exams | |
IA_ERP_1 | Participation on Disaster Medical Assistance Team, registered for 6 months. | |
IA_ERP_2 | Participation in a 60-day or greater effort to support domestic or international humanitarian needs. | |
IA_BMH_1 | Diabetes screening | |
IA_BMH_2 | Tobacco use | |
IA_BMH_3 | Unhealthy alcohol use | |
IA_BMH_4 | Depression screening | |
IA_BMH_5 | MDD prevention and treatment interventions | |
IA_BMH_6 | Implementation of co-location PCP and MH services | |
IA_BMH_7 | Implementation of Integrated Patient Centered Behavioral Health Model | |
IA_BMH_8 | Electronic Health Record Enhancements for BH data capture | |
IA_BMH_9 | Unhealthy Alcohol Use for Patients with Co-occurring Conditions of Mental Health and Substance Abuse and Ambulatory Care Patients | |
IA_BMH_10 | Completion of Collaborative Care Management Training Program | |
IA_PCMH | Electronic submission of Patient Centered Medical Home accreditation | |
COST_EOPCI_1 | Elective Outpatient Percutaneous Coronary Intervention (PCI) | Administrative Claims |
COST_CCLI_1 | Revascularization for Lower Extremity Chronic Critical Limb Ischemia | Administrative Claims |
COST_SPH_1 | Simple Pneumonia with Hospitalization | Administrative Claims |
COST_SSC_1 | Screening/Surveillance Colonoscopy | Administrative Claims |
COST_KA_1 | Knee Arthroplasty | Administrative Claims |
COST_IOL_1 | Routine Cataract Removal with Intraocular Lens (IOL) Implantation | Administrative Claims |
COST_IHCI_1 | Intracranial Hemorrhage or Cerebral Infarction | Administrative Claims |
COST_STEMI_1 | ST-Elevation Myocardial Infarction (STEMI) with Percutaneous Coronary Intervention (PCI) | Administrative Claims |
MSPB_1 | Medicare Spending Per Beneficiary (MSPB) | Administrative Claims |
TPCC_1 | Total Per Capita Costs (TPCC) | Administrative Claims |
AAAAI11 | Asthma Assessment and Classification | Registry |
AAAAI12 | Lung Function/Spirometry Evaluation | Registry |
AAAAI17 | Asthma Control: Minimal Important Difference Improvement | Registry |
AAAAI18 | Penicillin Allergy: Appropriate Removal or Confirmation | Registry |
AAAAI2 | Asthma: Assessment of Asthma Control - Ambulatory Care Setting | Registry |
AAAAI6 | Documentation of Clinical Response to Allergen Immunotherapy within One Year | Registry |
AAAAI8 | Achievement of Projected Effective Dose of Standardized Allergens for Patient Treated With Allergen Immunotherapy for at Least One Year | Registry |
AAAAI9 | Assessment of Asthma Symptoms Prior to Administration of Allergen Immunotherapy Injection(s) | Registry |
AAD2 | Psoriasis: Screening for Psoriatic Arthritis | Registry |
AAD5 | Biopsy: Reporting Time - Clinician to Patient | Registry |
ACMS1 | Adherence to Mohs Micrographic Surgery Appropriate Use Criteria | Registry |
AAPMR1 | Assessment and Management of Muscle Spasticity--Inpatient | Registry |
AAPMR2 | Management of Muscle Spasticity--Outpatient | Registry |
AAPMR3 | Functional Assessment to Determine Rehabilitation Needs | Registry |
AAPMR4 | Family Training-Inpatient Rehabilitation/Skilled Nursing Facility-Discharged to Home | Registry |
AAPMR5 | Post-Acute Brain Injury: Depression Screening and Follow-Up Plan of Care | Registry |
NPA24 | Narcotic Pain Medicine Management Following Elective Spine Procedure | Registry |
NPA25 | Depression and Anxiety Assessment Prior to Spine-Related Therapies | Registry |
NPA26 | Functional Outcome Assessment for Spine Intervention | Registry |
NPA27 | Spine/Extremity Pain Assessment | Registry |
NPA28 | Patient Satisfaction With Spine Care | Registry |
NPA29 | Quality-of-Life Assessment for Spine Intervention | Registry |
NPAGSC8 | Complication Following Percutaneous Spine-Related Procedure | Registry |
NPAGSC9 | Unplanned Admission to Hospital Following Percutaneous Spine Procedure within the 30-Day Post-procedure Period | Registry |
ABFM2 | Patients Admitted to ICU who Have Care Preferences Documented | Registry |
ABFM3 | Patients Treated with an Opioid Who Are Given a Bowel Regimen | Registry |
ABFM5 | Palliative Care-Treatment Preferences | Registry |
ABFM6 | Palliative Care Timely Dyspnea Screening & Treatment | Registry |
ABFM7 | Pain Brought Under Control within the first three visits | Registry |
ABFM8 | Measuring the Value-Functions of Primary Care: Provider Level Continuity Measure | Registry |
ABG16 | Planned use of difficult airway equipment | Registry |
ABG34 | Mood Assessment Screening and treatment | Registry |
ABG37 | Preoperative Screening for Anesthetic Risk Factors | Registry |
ABG38 | Second provider present for induction/intubation of known or suspected difficult airway | Registry |
ABG39 | Preoperative Active Warming | Registry |
ABG7 | Immediate Adult Post-Operative Pain Management | Registry |
AQI48 | Patient-Reported Experience with Anesthesia | Registry |
AQI55 | Team-Based Implementation of a Care-and-Communication Bundle for ICU Patients | Registry |
AQI56 | Use of Neuraxial Techniques and/or Peripheral Nerve Blocks for Total Knee Arthroplasty (TKA) | Registry |
AQI57 | Safe Opioid Prescribing Practices | Registry |
AQI58 | Infection Control Practices for Open Interventional Pain Procedures | Registry |
AQI59 | Multimodal Pain Management | Registry |
AQI61 | Ambulatory Post-Discharge Patient Follow-Up | Registry |
AQI62 | Obstructive Sleep Apnea: Patient Education | Registry |
AQI63 | Neuromuscular Blockade: Documented Assessment of Neuromuscular Function Prior to Extubation | Registry |
AQI64 | Neuromuscular Blockade: Reversal Administered | Registry |
AQI66 | Obstructive Sleep Apnea: Mitigation Strategies | Registry |
AQI67 | Consultation for Frail Patients | Registry |
ACEP19 | Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older | Registry |
ACEP20 | Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years | Registry |
ACEP21 | Coagulation Studies in Patients Presenting with Chest Pain with No Coagulopathy or Bleeding | Registry |
ACEP22 | Appropriate Emergency Department Utilization of CT for Pulmonary Embolism | Registry |
ACEP25 | Tobacco Use: Screening and Cessation Intervention for Patients with Asthma and COPD | Registry |
ACEP30 | Sepsis Management: Septic Shock: Lactate Clearance Rate of >= 10% | Registry |
ACEP31 | Appropriate Foley catheter use in the emergency department | Registry |
ACEP48 | Sepsis Management: Septic Shock: Lactate Level Measurement, Antibiotics Ordered, and Fluid Resuscitation | Registry |
ACEP50 | ED Median Time from ED arrival to ED departure for discharged ED patients for Adult Patients | Registry |
ACEP51 | ED Median Time from ED arrival to ED departure for discharged ED patients for Pediatric Patients | Registry |
ACQR10 | Syncope: complete evaluation | Registry |
ACQR11 | High Intensity Statin for patients with NSTEMI-ACS | Registry |
ACQR12 | ABCDEF Bundle - Early mobility for ICU patients | Registry |
ACQR13 | Sepsis: Hour One bundle | Registry |
ACQR14 | Use of HEART score for risk stratification in patients with suspected NSTEMI-ACS | Registry |
ACQR15 | Pneumonia: Use of CURB-65 for Risk Stratification in patient with CAP | Registry |
ACQR16 | COPD Exacerbation or CHF Exacerbation requiring Hospital Admission: Palliative Care Evaluation | Registry |
ACQR3 | COPD: Steroids for no more than 5 days in COPD Exacerbation | Registry |
ACQR7 | Sepsis Management: Septic Shock: Repeat Lactate Measurement Level Within 6 Hours | Registry |
ACQR9 | Use of ACE-I or ARB and beta blockade in CHF | Registry |
MA1 | Case Delay | Registry |
AHSQC10 | Ventral Hernia Repair: Pain and Functional Status Assessment | Registry |
AHSQC6 | Abdominal Wall Reconstruction Surgical Site Occurrence Requiring Procedural Intervention within the 30 Day Postoperative Period | Registry |
IRIS1 | Endothelial Keratoplasty - Post-operative improvement in best corrected visual acuity to 20/40 or better | Registry |
IRIS13 | Diabetic Macular Edema - Loss of Visual Acuity | Registry |
IRIS18 | Chronic Anterior Uveitis - Post-treatment visual acuity | Registry |
IRIS2 | Glaucoma - Intraocular Pressure (IOP) Reduction | Registry |
IRIS21 | Ocular Myasthenia Gravis: Improvement of ocular deviation or absence of diplopia or functional improvement | Registry |
IRIS22 | Giant Cell Arteritis: Absence of fellow eye involvement after treatment | Registry |
IRIS23 | Refractive Surgery: Patients with a postoperative uncorrected visual acuity (UCVA) of 20/20 or better | Registry |
IRIS24 | Refractive Surgery: Patients with a postoperative correction within + or - 0.5 Diopter (D) of the intended correction | Registry |
IRIS27 | Complications After Cataract Surgery | Registry |
IRIS35 | Improvement of Macular Edema in Patients with Uveitis | Registry |
IRIS36 | Visual Acuity Improvement Following Cataract Surgery Combined with a Trabeculectomy or an Aqueous Shunt Procedure | Registry |
IRIS37 | Post-operative opioid management following oculoplastic surgery | Registry |
IRIS38 | Endothelial Keratoplasty - Dislocation Requiring Surgical Intervention | Registry |
IRIS39 | Intraocular Pressure Reduction Following Trabeculectomy or an Aqueous Shunt Procedure | Registry |
IRIS40 | Regaining Vision After Cataract Surgery | Registry |
IRIS41 | Improved visual acuity after epiretinal membrane treatment within 120 days | Registry |
IRIS42 | Return to the OR or endophthalmitis within 90 days after epiretinal membrane surgical treatment | Registry |
IRIS43 | Intraocular Pressure Reduction Following Laser Trabeculoplasty | Registry |
IRIS44 | Visual Field Progression in Glaucoma | Registry |
IRIS45 | Exudative Age-Related Macular Degeneration: Loss of Visual Acuity | Registry |
IRIS46 | Evidence of anatomic closure of macular hole within 90 days after surgery as documented by OCT | Registry |
IRIS47 | Return to the OR or endophthalmitis within 90 days after macular hole surgery | Registry |
IRIS48 | Adult Surgical Esotropia: Postoperative alignment | Registry |
IRIS49 | Surgical Pediatric Esotropia: Postoperative alignment | Registry |
IRIS5 | Surgery for Acquired Involutional Ptosis: Patients with an improvement of marginal reflex distance (MRD) | Registry |
IRIS50 | Amblyopia: Interocular visual acuity | Registry |
IRIS51 | Acute Anterior Uveitis: Post-treatment visual acuity | Registry |
IRIS6 | Acquired Involutional Entropion: Normalized lid position after surgical repair | Registry |
AAN24 | Vestibular Rehabilitation for Unilateral or Bilateral Vestibular Hypofunction | Registry |
AAO12 | Tympanostomy Tubes: Topical Ear Drop Monotherapy Acute Otorrhea | Registry |
AAO13 | Bell's Palsy: Inappropriate Use of Magnetic Resonance Imaging or Computed Tomography Scan (Inverse Measure) | Registry |
AAO16 | Age-related Hearing Loss: Audiometric Evaluation | Registry |
AAO17 | Age-related Hearing Loss: Advanced Diagnostic Imaging of Bilateral Presbycusis or Symmetric SNHL | Registry |
AAO20 | Tympanostomy Tubes: Hearing Test | Registry |
AAO21 | Otitis Media with Effusion: Hearing Test for Chronic OME > 3 months | Registry |
AAO23 | Allergic Rhinitis: Intranasal Corticosteroids or Oral Antihistamines | Registry |
AAO24 | Allergic Rhinitis: Avoidance of Leukotriene Inhibitors | Registry |
AAO27 | Tympanostomy Tubes: Resolution of Otitis Media with Effusion in Children | Registry |
AAO28 | Tympanostomy Tubes: Resolution of Otitis Media with Effusion in Adults | Registry |
AAO29 | Quality of Life for Patients with Neurotology Disorders | Registry |
AAO30 | Early Oral Cancer: Staging and Treatment | Registry |
AAO31 | Otitis Media with Effusion (OME): Avoidance of Inappropriate Use of Medications | Registry |
AAO32 | Standard BPPV Management | Registry |
AAO33 | Age-related Hearing Loss: Shared Decision Making | Registry |
AAO34 | Dysphonia: Postoperative Laryngeal Examination | Registry |
AAO35 | Benign Positional Paroxysmal Vertigo (BPPV): Dix-Hallpike and Canalith Repositioning | Registry |
ASPS16 | Airway Assessment for patients undergoing Rhinoplasty | Registry |
ASPS17 | Patient Satisfaction with Rhinoplasty Procedure | Registry |
ASPS18 | Shared-decision making for post-operative management of discomfort following Rhinoplasty | Registry |
ASPS19 | Pre-surgical discussion of motivations and outcomes for patients undergoing Rhinoplasty | Registry |
ACMT1 | Screening for risk of opioid misuse/overuse | Registry |
ACMT2 | Pregnancy test in women with a suspected toxicologic exposure | Registry |
ACMT3 | EKG assessment in acute overdoses | Registry |
ACMT4 | Appropriate treatment for acetaminophen ingestions | Registry |
ACMT5 | Assessment of suspected ethylene glycol or methanol exposures | Registry |
ACMT6 | Repeat assessment of salicylate concentrations in overdose patients | Registry |
ACPGR1 | High Risk Pneumococcal Vaccination | Registry |
ACPGR2 | Tdap (Tetanus, Diphtheria, Acellular Pertussis) Vaccination | Registry |
ACRAD1 | CT Colonography True Positive Rate | Registry |
ACRAD15 | Report Turnaround Time: Radiography | Registry |
ACRAD16 | Report Turnaround Time: Ultrasound (Excluding Breast US) | Registry |
ACRAD17 | Report Turnaround Time: MRI | Registry |
ACRAD18 | Report Turnaround Time: CT | Registry |
ACRAD19 | Report Turnaround Time: PET | Registry |
ACRAD25 | Report Turnaround Time: Mammography | Registry |
ACRAD26 | Appropriate venous access for hemodialysis | Registry |
ACRAD29 | Rate of percutaneous nephrostomy tube replacement within 30 days secondary to dislodgement | Registry |
ACRAD30 | Rate of Inadequate Percutaneous Image-Guided Biopsy | Registry |
ACRAD34 | Multi-strata weighted average for 3 CT Exam Types: Overall Percent of CT exams for which Dose Length Product is at or below the size-specific diagnostic reference level (for CT Abdomen-pelvis with contrast/single phase scan, CT Chest without contrast/single phase scan and CT Head/Brain without contrast/single phase scan) | Registry |
ACRAD35 | Screening Mammography Early Cancer Detection Rate | Registry |
AQUA12 | Benign Prostate Hyperplasia: IPSS improvement after diagnosis | Registry |
AQUA14 | Stones: Repeat Shock Wave Lithotripsy (SWL) within 6 months of treatment | Registry |
AQUA15 | Stones: Urinalysis documented 30 days before surgical stone procedures | Registry |
AQUA16 | Non-Muscle Invasive Bladder Cancer: Repeat Transurethral Resection of Bladder Tumor (TURBT) for T1 disease | Registry |
AQUA17 | Non-Muscle Invasive Bladder Cancer: Initiation of BCG within 3 months of diagnosis of high-grade T1 bladder cancer and/or CIS | Registry |
AQUA18 | Non-Muscle Invasive Bladder Cancer: Early surveillance cystoscopy within 4 months of initial diagnosis | Registry |
AQUA19 | Diagnosis of Type of Azoospermia and Diagnostic Testing for Obstructive Azoospermia | Registry |
AQUA21 | Appropriate Management of Obstructive Azoospermia | Registry |
AQUA22 | Bone imaging and soft tissue imaging within 30 days (before or after) of diagnosis of metastatic CRPC | Registry |
AQUA23 | Blood work for patients receiving abiraterone | Registry |
AQUA24 | Testosterone and PSA levels checked for CRPC patients | Registry |
AQUA25 | Use of Prednisone for CRPC patients on abiraterone | Registry |
AQUA26 | Benign Prostate Hyperplasia Care: Benign Prostate Hyperplasia | Registry |
AQUA27 | Appropriate Testing for Vasectomy Patients | Registry |
AQUA29 | Prostate Cancer: Patient Report of Urinary function after treatment | Registry |
AQUA30 | Prostate Cancer: Patient Report of Sexual function after treatment | Registry |
AQUA31 | Prostate Cancer: Documentation of PSA, Gleason score and clinical stage for risk stratification | Registry |
AQUA32 | Hypogonadism: Laboratory evaluation conducted within 6 months of starting testosterone replacement | Registry |
AQUA33 | Intracavernosal Injection Therapy In-Office Test | Registry |
AQUA34 | Genetic Testing and Patient Counseling of the Azoospermic Male | Registry |
MUSIC10 | Prostate Cancer: Confirmation Testing in low risk AS eligible patients | Registry |
MUSIC11 | Prostate Cancer: Follow-Up Testing for patients on active surveillance for at least 30 months | Registry |
MUSIC4 | Prostate Cancer: Active Surveillance/Watchful Waiting for Low Risk Prostate Cancer Patients | Registry |
QOPI21 | Oncology: Treatment Summary Communication - Radiation Oncology | Registry |
QOPI22 | External Beam Radiotherapy for Bone Metastases | Registry |
AQI18 | Coronary Artery Bypass Graft (CABG): Prolonged Intubation - Inverse Measure | Registry |
AQI49 | Adherence to Blood Conservation Guidelines for Cardiac Operations using Cardiopulmonary Bypass (CPB) - Composite | Registry |
AQI65 | Avoidance of Cerebral Hyperthermia for Procedures Involving Cardiopulmonary Bypass | Registry |
QUANTUM31 | Central Line Ultrasound Guidance | Registry |
EPREOP29 | Preoperative Assessment for Opioid Dependence Risk | Registry |
EPREOP30 | Ultrasound Guidance for Peripheral Nerve Block with Patient Experience | Registry |
CCOME1 | Patient-Reported Pain and/or Function Improvement after Total Knee Arthroplasty | Registry |
AUGS1 | Complete assessment and evaluation of patient's pelvic organ prolapse prior to surgical repair | Registry |
AUGS10 | Documentation of offering a preoperative pessary for Pelvic Organ Prolapse | Registry |
AUGS11 | Documentation that a trial of conservative management was offered prior to use of procedure based therapy for urgency urinary incontinence | Registry |
AUGS5 | Performing vaginal apical suspension at the time of hysterectomy to address pelvic organ prolapse | Registry |
AUGS6 | Route of Hysterectomy | Registry |
AUGS7 | Documentation that conservative management was offered prior to fecal incontinence surgery or procedures | Registry |
AUGS8 | Documentation of weight loss counseling prior to surgery for stress urinary incontinence procedures for obese women | Registry |
AUGS9 | Over-utilization of synthetic mesh in the posterior compartment | Registry |
ASPS10 | Patient Satisfaction with Information Provided during Breast Reconstruction | Registry |
ASPS11 | Operative Time for Autologous Breast Reconstruction | Registry |
ASPS12 | Unplanned hospital admission after panniculectomy | Registry |
ASPS20 | Wound complications after primary panniculectomy in patients with BMI > or = to 30 | Registry |
ASPS5 | Breast Reconstruction: Return to OR | Registry |
ASPS7 | Rate of Blood Transfusion for Patients Undergoing Autologous Breast Reconstruction | Registry |
ASPS8 | Coordination of Care for Patients Undergoing Breast Reconstruction | Registry |
ASPS9 | Length of Stay Following Autologous Breast Reconstruction | Registry |
CDR1 | Adequate Off-loading of Diabetic Foot Ulcer at each visit | Registry |
AAN1 | Diabetes/Pre-Diabetes Screening for Patients with DSP | Registry |
AAN10 | Falls screening (aggregation of AAN disease specific falls measures) | Registry |
AAN11 | Overuse of barbiturate and opioid containing medications for primary headache disorders | Registry |
AAN12 | Quality of Life Outcome for Patients with Epilepsy | Registry |
AAN14 | Current MS Disability Scale Score | Registry |
AAN19 | Botulinum Toxin Serotype A (BoNT-A) for spasticity or dystonia | Registry |
AAN20 | Querying and follow-up for co-morbid conditions of tic disorder (TD) and Tourette syndrome (TS) | Registry |
AAN22 | Global Health | Registry |
AAN23 | Avoidance of Dopamine-Blocking Medications in Patients with Parkinson's Disease | Registry |
AAN25 | Pediatric Medication reconciliation | Registry |
AAN26 | Activity counseling for back pain | Registry |
AAN27 | Falls plan of care | Registry |
AAN5 | Medication Prescribed For Acute Migraine Attack | Registry |
AAN8 | Exercise and Appropriate Physical Activity Counseling for Patients with MS | Registry |
AAN9 | Querying About Symptoms of Autonomic Dysfunction for Patients with Parkinson's Disease | Registry |
MICS4 | Pain, Function and General Health Postoperative Improvement | Registry |
CCOME2 | Patient-Reported Pain and/or Function Improvement after Total Hip Arthroplasty | Registry |
CCOME3 | Patient-Reported Pain and/or Function Improvement after Total Shoulder Arthroplasty | Registry |
CCOME4 | Patient-Reported Pain and/or Function Improvement after ACLR Surgery | Registry |
CCOME5 | Extent of Osteoarthritis Observed in Arthroscopic Partial Meniscectomy | Registry |
CCOME6 | Patient-Reported Pain and/or Function Improvement after APM Surgery | Registry |
CLLC4 | Foot Bone Infection Diagnosis Without MRI | Registry |
CLLC5 | Monitoring for albuminuria in patients with CKD | Registry |
CLLC6 | Appropriate dosages of H2 blockers in patients with CrCl < 50 ml/min | Registry |
CLLC7 | Renal Dysfunction: New Oral Anticoagulants (NOACs) Management | Registry |
PPRNET13 | Chronic Kidney Disease (CKD): eGFR Monitoring | Registry |
PPRNET14 | Chronic Kidney Disease (CKD): Hemoglobin Monitoring | Registry |
PPRNET24 | Appropriate Treatment for Adults with Upper Respiratory Infection | Registry |
PPRNET31 | Screening for Type 2 Diabetes | Registry |
PPRNET32 | Screening for albuminuria in patients at risk for CKD (DM and/or HTN) | Registry |
PPRNET33 | Avoiding Use of CNS Depressants in Patients on Long-Term Opioids | Registry |
PPRNET8 | Antiplatelet Medication for High Risk Patients | Registry |
SCG6 | Outcome of High Risk Pain Medications Prescribed in Last 6 Months | Registry |
SCG7 | Evaluation of High Risk Pain Medications for MME | Registry |
CODE10 | Improved Global Physical Health Outcome Assessment for Shoulder Arthroscopy | Registry |
CODE12 | Improved Functional Outcome Assessment for Hip Arthroscopy | Registry |
CODE3 | Improved Functional Outcome Assessment for Foot/Ankle Repair | Registry |
CODE5 | Improved Global Physical Health Outcome Assessment for Spine Surgery | Registry |
CODE9 | Improved Global Physical Health Outcome Assessment for Hand/Wrist/Elbow Repair | Registry |
CESQIP1 | Post operative hypocalcemia after thyroidectomy surgery | Registry |
CESQIP3 | Pre operative ultrasound exam of patients with thyroid cancer | Registry |
CESQIP5 | Related readmission for adrenal related problems | Registry |
CUHSM3 | CAHPS Group Surveys - (Adult Primary Care, Pediatric Care, and Specialist Care Surveys) | Registry |
CUHSM4 | CAHPS Health Plan Survey v 4.0 - Adult questionnaire | Registry |
CUHSM6 | Adherence to Mood Stabilizers for Individuals with Bipolar I Disorder | Registry |
CUHSM8 | Cardiovascular Health Screening for People With Schizophrenia or Bipolar Disorder Who Are Prescribed Antipsychotic Medications | Registry |
ECPR39 | Avoid Head CT for Patients with Uncomplicated Syncope | Registry |
ECPR40 | Initiation of the Initial Sepsis Bundle | Registry |
ECPR41 | Rh Status Evaluation and Treatment of Pregnant Women at Risk of Fetal Blood Exposure | Registry |
ECPR42 | Restrictive Use of Blood Transfusions | Registry |
ECPR45 | Avoidance of Creatine Kinase-MB (CK-MB) Testing for Non-traumatic Chest Pain | Registry |
ECPR46 | Avoidance of Opiates for Low Back Pain or Migraines | Registry |
ECPR47 | Avoidance of Opiate Prescriptions for Greater Than 3 Days Duration for Acute Pain | Registry |
ECPR48 | Avoidance of Long-Acting (LA) or Extended-Release (ER) Opiate Prescriptions | Registry |
ECPR5 | Mean Time from Emergency Department (ED) Arrival to ED Departure for Discharged Lower Acuity ED Patients | Registry |
ECPR50 | Door to Diagnostic Evaluation by a Provider Within 30 Minutes - Urgent Care Patients | Registry |
ECPR51 | Discharge Prescription of Naloxone after Opioid Poisoning or Overdose | Registry |
ECPR52 | Appropriate Treatment of Psychosis and Agitation in the Emergency Department | Registry |
ECPR53 | Clinician Reporting of Loss of Consciousness to State Department of Public Health or Department of Motor Vehicles | Registry |
ECPR6 | Mean Time from Emergency Department (ED) Arrival to ED Departure for Discharged Higher Acuity ED Patients | Registry |
EMIQ1 | tPA and Endovascular Therapy Considered for Stroke Patients | Registry |
FOTO1 | Functional Status Change for Patients with Neck Impairments | Registry |
GIQIC10 | Appropriate management of anticoagulation in the peri-procedural period rate - EGD | Registry |
GIQIC12 | Appropriate indication for colonoscopy | Registry |
GIQIC15 | Appropriate follow-up interval of 3 years recommended based on pathology findings from screening colonoscopy in average-risk patients | Registry |
GIQIC17 | Appropriate follow-up interval of 5 years for colonoscopies with findings of sessile serrated polyps < 10 mm without dysplasia | Registry |
GIQIC19 | Appropriate indication for esophagogastroduodenoscopy (EGD) | Registry |
GIQIC21 | Appropriate follow-up interval of not less than 5 years for colonoscopies with findings of 1-2 tubular adenomas < 10 mm OR of 10 years for colonoscopies with only hyperplastic polyp findings in rectum or sigmoid | Registry |
NHCR4 | Repeat screening or surveillance colonoscopy recommended within one year due to inadequate/poor bowel preparation | Registry |
HF4 | Shoulder Arthroscopy: Measure of Change in a Validated Shoulder Patient Reported Outcome Following Shoulder Arthroscopy | Registry |
HF7 | Surgical Repair for Rotator Cuff Tear: Change in a Validated Shoulder Patient Reported Outcome Measure Following Surgical Rotator Cuff Repair | Registry |
HF8 | Knee Arthroscopy for Meniscal Repair: Change in a Validated Knee Measure Following Knee Arthroscopy for Meniscal Repair | Registry |
IROMS11 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in knee rehabilitation of patients with knee injury measured via their validated Knee Outcome Survey (KOS) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID. | Registry |
IROMS13 | Failure to Progress (FTP): Proportion of patients not achieving a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with hip, leg or ankle injuries using the validated Lower Extremity Function Scale (LEFS) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID. | Registry |
IROMS15 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with neck pain/injury measured via the validated Neck Disability Index (NDI). | Registry |
IROMS19 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with arm, shoulder, and hand injury measured via the validated Disability of Arm Shoulder and Hand (DASH) score, Quick Disability of Arm Shoulder and Hand (QDASH) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID. | Registry |
HCPR14 | Venous Thromboembolism (VTE) Prophylaxis | Registry |
HCPR16 | Physician's Orders for Life-Sustaining Treatment (POLST) Form | Registry |
HCPR17 | Pressure Ulcers - Risk Assessment and Plan of Care | Registry |
HCPR18 | Unintentional Weight Loss - Risk Assessment and Plan of Care | Registry |
HCPR19 | 30 Day All Cause Readmit Rate for Discharged Inpatients | Registry |
HCPR20 | Clostridium Difficile - Risk Assessment and Plan of Care | Registry |
HCPR21 | Appropriate Use of Telemetry for Admission or Observation Placement | Registry |
HCPR22 | Critical Care Transfer of Care - Use of Verbal Checklist or Protocol | Registry |
HCPR3 | Mean Length of Stay for Inpatients - Pneumonia | Registry |
HCPR4 | Mean Length of Stay for Inpatients - CHF | Registry |
HCPR5 | Mean Length of Stay for Inpatients - COPD | Registry |
HADV1 | Use of high risk sleep medications in the elderly | Registry |
HADV2 | Atrial Fibrillation Prevention and Treatment - Lifestyle and Disease Factor Assessment | Registry |
HADV3 | Emergency Department effective use of a HEART (History, ECG, Age, Risk factors, Troponin) Score for treatment of patients presenting with nontraumatic chest pain. | Registry |
HMIQ1 | Discharge Summary Completed within 1 Day of Discharge Date | Registry |
HMIQ2 | Follow-Up Care Coordination Documented in Discharge Summary | Registry |
ASNC19 | Imaging Protocols for SPECT and PET MPI studies - Use of stress only protocol | Registry |
ASNC23 | SPECT-MPI study clinical utilization of Attenuation Correction image acquisition | Registry |
ASNC28 | SPECT-MPI effective dose less than or equal to 9 millisieverts as per ASNC guideline recommendations | Registry |
ASNC29 | SPECT and PET MPI study documentation of stress perfusion defects | Registry |
ASNC30 | Transthoracic Echo (TTE) studies meeting appropriate use criteria | Registry |
IGR1 | Comprehensive TTE studies reporting a measured value of LVEF AND wall motion findings with LVEF < 50% | Registry |
IGR10 | Transthoracic Echo (TTE) performance per ASE guidelines | Registry |
IGR2 | Parameters in dobutamine testing for low flow, low gradient aortic stenosis | Registry |
IGR3 | Myocardial Perfusion Imaging (MPI) or Stress Echocardiography studies meeting appropriate use criteria | Registry |
IGR4 | Myocardial Perfusion Imaging (MPI) studies or Stress Echocardiography imaging studies not Equivocal | Registry |
IGR5 | Myocardial Perfusion Imaging (MPI) studies, Transthoracic Echo (TTE), or Stress Echocardiography imaging studies reporting Left Ventricular Ejection Fraction | Registry |
IGR6 | SPECT-MPI or Stress Echocardiography imaging protocol selection for morbidly obese patients | Registry |
IGR7 | SPECT-MPI or Stress Echocardiography imaging studies with adequate exercise testing performed | Registry |
IGR8 | SPECT-MPI or Stress Echocardiography study utilization of exercise as a stressor | Registry |
IGR9 | Stress echo performance for shortness of breath per ASE guidelines | Registry |
IROMS12 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in revalidation patients with knee injury pain. | Registry |
IROMS14 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with hip, leg or ankle (lower extremity except knee) injury. | Registry |
IROMS16 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with neck pain/injury. | Registry |
IROMS17 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation patients with low back pain measured via the validated Modified Low Back Pain Disability Questionnaire (MDQ) score. | Registry |
IROMS18 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in revalidation patients with low back pain. | Registry |
IROMS20 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with arm, shoulder, or hand injury. | Registry |
K2MISSG1 | Minimum Clinically Important Difference (MCID) of Patient-Reported Outcome Measurement Information System Computer Adapted Testing Physical Function Domain (PROMIS CAT PF) in Spine Surgery Patients | Registry |
IQSS1 | Hypogonadism: Serum T, CBC, PSA, IPSS within 6 months of Rx | Registry |
IQSS2 | Prostate Cancer: Newly diagnosed with documented T stage, PSA score, and Gleason score | Registry |
IQSS3 | Prostate Cancer: Treatment Options Counseling | Registry |
IQSS4 | BPH: Anticholinergics | Registry |
MBHR1 | Anxiety Utilization of the GAD-7 Tool | Registry |
MBHR2 | Anxiety Response at 6-months | Registry |
MBHR3 | Pain Interference Response utilizing PROMIS | Registry |
MBHR4 | Social Role Functioning Outcome utilizing PROMIS | Registry |
MBHR5 | Screening and monitoring for psychosocial problems among children and youth | Registry |
MBHR6 | Sleep Quality Screening and Sleep Response at 3-months | Registry |
MBSAQIP10 | Risk standardized rate of patients who experienced a postoperative escalation in care event following a primary Laparoscopic Roux-en-Y Gastric Bypass or Laparoscopic Sleeve Gastrectomy operation | Registry |
MBSAQIP11 | Risk standardized rate of patients who experienced a pulmonary complication following a primary Laparoscopic Roux-en-Y Gastric Bypass or Laparoscopic Sleeve Gastrectomy | Registry |
MBSAQIP8 | Risk standardized rate of patients who experienced an extended length of stay (> 3 days) following a primary Laparoscopic Roux-en-Y Gastric Bypass or Laparoscopic Sleeve Gastrectomy operation | Registry |
MEDNAX52 | Use of a "PEG Test" to Manage Patients Receiving Opioids | Registry |
MEDNAX53 | Use of Capnography for non-Operating Room anesthesia | Registry |
MEDNAX54 | Labor Epidural Failure when Converting from Labor Analgesia to Cesarean Section Anesthesia | Registry |
MEDNAX55 | Use of ASPECTS (Alberta Stroke Program Early CT Score) for non-contrast CT Head performed for suspected acute stroke. | Registry |
MEX1 | Heel Pain Treatment Outcomes for Adults | Registry |
MEX14 | Foot Ulcer Prevention | Registry |
MEX2 | Heel Pain Treatment Outcomes for Pediatric Patients | Registry |
MEX3 | Identification of Flat Foot in Pediatric Patients | Registry |
MEX4 | Bunion Outcome - Adult and Adolescent | Registry |
MEX5 | Hammer Toe Outcome | Registry |
MUSIC12 | Kidney Stones: ED visit within 30 days of ureteroscopy | Registry |
MUSIC13 | Kidney Stones: Antibiotics should not be provided at the time of SWL | Registry |
MUSIC14 | Kidney Stones: Alphablockers at discharge for patients undergoing kidney stone surgery, Ureteroscopy or Shockwave Lithotripsy | Registry |
MUSIC15 | Kidney Stones: SWL in patients with total renal stone burden > 2 cm or > 1 cm lower pole stones | Registry |
MUSIC16 | Kidney Stones: Opioid utilization after ureteroscopy | Registry |
MUSIC3 | Prostate Cancer: Avoidance of Overuse of CT Scan for Staging Low Risk Prostate Cancer Patients | Registry |
MUSIC5 | Prostate Cancer: Radical Prostatectomy Cases LOS | Registry |
MIRAMED16 | Perioperative Pain Plan | Registry |
MIRAMED19 | Onset atrial fibrillation or dysrhythmia requiring unanticipated therapy | Registry |
MIRAMED20 | Perioperative cognitive function test in elderly | Registry |
MIRAMED21 | Propofol Management of Obese Patients | Registry |
MIRAMED22 | New acute respiratory failure | Registry |
ACMS2 | Closing the Mohs Surgery Referral Loop: Transmission of Surgical Report | Registry |
ACMS3 | Antibiotic Prophylaxis for High Risk Cardiac / Orthopedic Cases prior to Mohs micrographic surgery - Prevention of Overuse | Registry |
ACMS4 | Surgical Site Infection Rate - Mohs Micrographic Surgery | Registry |
MUSE1 | CollaboRATE Shared Decision Making Score | Registry |
NHBPC10 | Telephone Contact, Virtual, or In-person Visit Within 48 Hours of Hospital Discharge of Home-Based Primary Care and Palliative Care Patients | Registry |
NHBPC14 | Cognitive Assessment and Plan of Care for Home-Based Primary Care and Palliative Care Patients | Registry |
NHBPC15 | Functional Assessment (Basic and Instrumental Activities of Daily Living [ADL]) for Home-Based Primary Care and Palliative Care Patients | Registry |
NHBPC17 | Screening for Depression and Follow-up Plan in Home-Based Primary Care and Palliative Care Patients | Registry |
NHBPC2 | Alcohol Problem Use Assessment & Brief Intervention for Home-Based Primary Care and Palliative Care Patients | Registry |
NHBPC7 | Delirium Assessment in Home-Based Primary Care and Palliative Care Patients: Medication List Reviewed & Offending Medications Discontinued (Multiperformance-Rate Measure) | Registry |
NHBPC9 | Referral to Hospice for Appropriate Home-Based Primary Care and Palliative Care Patients | Registry |
NOF12 | Median Time to Pain Management for Long Bone Fracture | Registry |
NOF13 | Osteoporosis: Management Following Fracture of Hip, Spine or Distal Radius for Men and Women Aged 50 Years and Older | Registry |
NPQR1 | Notification to the ordering provider requesting myoglobin or CK-MB in the diagnosis of suspected acute myocardial infarction (AMI) | Registry |
NPQR11 | Rate of communicating results of an amended report with a major discrepancy to the responsible provider | Registry |
NPQR12 | Rate of cytopathology case review | Registry |
NPQR13 | Rate of notification to clinical provider of a new diagnosis of malignancy | Registry |
NPQR14 | Frozen Section Diagnosis within 20 Minutes of Receipt in Lab (Single Specimen, Single Block Frozen Section) | Registry |
NPQR2 | Notification to the ordering provider requesting thyroid screening tests other than only a Thyroid Stimulating Hormone (TSH) test in the initial screening of a patient with a suspected thyroid disorder | Registry |
NPQR3 | Notification to the ordering provider requesting amylase testing in the diagnosis of suspected acute pancreatitis | Registry |
NPQR4 | Time interval: critical value reporting for chemistry | Registry |
NPQR5 | Time interval: critical value reporting for cerebrospinal fluid - white blood cell (CSF - WBC) | Registry |
NPQR6 | Time interval: critical value reporting for toxicology | Registry |
NPQR7 | Time interval: critical value reporting for troponin | Registry |
NPQR8 | Rate of review of slides with high-grade squamous intraepithelial lesion (HSIL) with negative cervical biopsies | Registry |
NPQR9 | Rate of follow up letter after high-grade squamous intraepithelial lesion (HSIL) pap test | Registry |
NHCR5 | Repeat colonoscopy recommended due to piecemeal resection | Registry |
OBERD22 | Post Stroke Outcome and Follow-Up | Registry |
OBERD23 | Health Related Quality of Life: Patient Defined Outcomes | Registry |
OBERD25 | Tracking Satisfaction Improvement with CG-CAHPS | Registry |
OBERD28 | Hip Functional Outcomes | Registry |
OBERD31 | Quality of Life-Mental Health Outcomes | Registry |
OBERD32 | Quality of Life - Physical Health Outcomes | Registry |
OBERD33 | Patient Acceptable Symptom State Outcomes | Registry |
OBERD34 | Upper Extremity Functional Outcomes | Registry |
SPINETRACK4 | Percent of patients meeting SCB thresholds for back or neck pain | Registry |
SPINETRACK6 | Percent of patients meeting SCB thresholds for pain-related disability (ODI/NDI) | Registry |
ONSQIR16 | Recommendation for Exercise to Adult Cancer Survivors | Registry |
ONSQIR18 | Goal Setting and Attainment for Cancer Survivors | Registry |
ONSQIR21 | Patient Reported Health-Related Quality of Life (HRQOL) during Treatment for Advanced Cancer | Registry |
ONSQIR22 | PCR Test with MR2 or greater result (BCR-ABL1 transcript level <= 1% [IS]) for patients receiving TKI for at least 6 months for Chronic Myelogenous Leukemia | Registry |
ONSQIR23 | Assessment for and management of immune-related adverse events during cancer treatment with checkpoint inhibitors (ICPi) | Registry |
OEIS2 | Emergent transfer from an outpatient, ambulatory surgical center, or office setting | Registry |
OEIS6 | Appropriate non-invasive arterial testing for patients with intermittent claudication who are undergoing a LE peripheral vascular intervention | Registry |
OEIS7 | Structured Walking Program Prior to Intervention for Claudication | Registry |
CAP10 | Blood Laboratory Samples for Potassium Determination with Hemolysis Drawn in ED | Registry |
CAP11 | Accurate Human Epidermal Growth Factor Receptor 2 (HER2) Tumor Evaluation and Repeat Evaluation in Patients with Breast Carcinoma | Registry |
CAP12 | Accurate Human Epidermal Growth Factor Receptor 2 (HER2) Tumor Evaluation and Repeat Evaluation in Patients with Gastroesophageal Adenocarcinoma | Registry |
CAP13 | Anaplastic Lymphoma Kinase (ALK) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Non-small Cell Lung Cancer | Registry |
CAP14 | Appropriate Formalin Fixation Time (6 - 72 hours) of Breast Cancer Specimens to Ensure Accurate Ancillary Testing Results | Registry |
CAP15 | BRAF Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Metastatic Colorectal Adenocarcinoma | Registry |
CAP16 | Epidermal Growth Factor Receptor (EGFR) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Non-small Cell Lung Cancer | Registry |
CAP17 | FMS-like Tyrosine 3-Internal Tandem Duplication (FLT3-ITD) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Acute Myeloid Leukemia | Registry |
CAP18 | Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Primary or Metastatic Colorectal Carcinoma | Registry |
CAP19 | ROS 1 Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Non-small Cell Lung Cancer | Registry |
CAP20 | High Risk HPV Testing and p16 Scoring in Surgical Specimens for Patients with Oropharyngeal Squamous Cell Carcinoma (OPSCC) | Registry |
CAP21 | High Risk HPV Testing in Cytopathology Specimens for Patients with Oropharyngeal Squamous Cell Carcinoma (OPSCC) | Registry |
CAP22 | Turnaround Time (TAT) - Biopsies | Registry |
CAP23 | Cancer Protocol Elements and Turnaround Time for Carcinoma and Carcinosarcoma of the Endometrium | Registry |
CAP24 | Cancer Protocol Elements and Turnaround Time for Carcinoma of the Intrahepatic Bile Ducts | Registry |
CAP25 | Cancer Protocol Elements and Turnaround Time for Carcinoma of the Pancreas | Registry |
CAP26 | Cancer Protocol Elements and Turnaround Time for Hepatocellular Carcinoma | Registry |
CAP27 | Cancer Protocol Elements and Turnaround Time for Invasive Carcinoma of Renal Tubular Origin | Registry |
CAP28 | Helicobacter pylori Status and Turnaround Time | Registry |
CAP8 | Turnaround Time (TAT) - Lactate | Registry |
CAP9 | Turnaround Time (TAT) - Troponin | Registry |
FORCE20 | Review of Functional Status Assessment for Patients with Osteoarthritis | Registry |
FORCE21 | Review of Pain Status Assessment for Patients with Osteoarthritis | Registry |
WCHQ10 | Diabetes Care All or None Outcome Measure: Optimal Control | Registry |
WCHQ15 | Screening For Osteoporosis | Registry |
WCHQ32 | Controlling High Blood Pressure: eGFR Test Annually | Registry |
WCHQ9 | Diabetes Care All or None Process Measure: Optimal Testing | Registry |
ACCPIN10 | Hypertension: Blood Pressure Treatment and Control for Stage 2 Hypertensive Patients | Registry |
ACCPIN7 | Peripheral Artery Disease: Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk | Registry |
ACCPIN8 | Hypertension: Blood Pressure Control for Stage 1 or 2 Hypertensive Patients | Registry |
ACCPIN9 | Hypertension: Blood Pressure Treatment and Control for High Risk Patients | Registry |
ARCO15 | Diabetes: Nutritional, Weight Loss Counseling, Reduction of Sedentary Behavior | Registry |
PIMSH1 | Advance Care Planning in Stage 4 Disease | Registry |
PIMSH4 | Oncology: Patient-Reported Pain Improvement | Registry |
PIMSH5 | Oncology: Supportive Care Drug Utilization in Last 14 Days of Life | Registry |
PIMSH8 | Oncology: Mutation Testing for Lung Cancer (i.e. EGFR, alk, ROS) Completed Prior to Start of Therapy | Registry |
PINC1 | Risk-adjusted 30 day Readmission for Acute Myocardial Infarction | Registry |
PINC2 | Risk-adjusted 30 day Readmission for Heart Failure | Registry |
PINC3 | Risk-adjusted 30 day Readmission for Pneumonia | Registry |
PINC33 | Risk-Adjusted Average Length of Inpatient Hospital Stay for Acute Myocardial Infarction | Registry |
PINC34 | Risk-Adjusted Average Length of Inpatient Hospital Stay for Heart Failure | Registry |
PINC35 | Risk-Adjusted Average Length of Inpatient Hospital Stay for Pneumonia | Registry |
PINC4 | Risk-adjusted 30 day Inpatient Mortality for Acute Myocardial Infarction | Registry |
PINC5 | Risk-adjusted 30 day Inpatient Mortality for Heart Failure | Registry |
PINC6 | Risk-adjusted 30 day Inpatient Mortality for Pneumonia | Registry |
ARCO3 | Antipsychotic Use in Persons with Dementia | Registry |
PP2 | Follow-Up After Hospitalization for Schizophrenia (7- and 30-day) | Registry |
PP4 | Risky Behavior Assessment or Counseling by Age 18 Years | Registry |
PP5 | Bipolar disorder: the percentage of patients diagnosed and treated for bipolar disorder who are monitored for change in their symptom complex within 12 weeks of initiating treatment; AND if there is no change or deterioration in symptoms, a revised care plan is documented following the 12 week monitoring phase | Registry |
PP7 | Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC) | Registry |
QOPI11 | Combination chemotherapy received within 4 months of diagnosis by women under 70 with AJCC stage IA (T1c) to III ER/PR negative breast cancer | Registry |
QOPI15 | GCSF administered to patients who received chemotherapy for metastatic cancer (Lower Score -Better) | Registry |
QOPI23 | Concurrent Chemoradiation for Patients with a Diagnosis of Stage IIIB NSCLC | Registry |
QOPI5 | Chemotherapy administered to patients with metastatic solid tumor with performance status of 3, 4, or undocumented (Lower Score - Better) | Registry |
NPA11 | Unplanned Readmission Following Spine Procedure within the 30-Day Postoperative Period | Registry |
NPA12 | Selection of Prophylactic Antibiotic Prior to Spine Procedure | Registry |
NPA18 | Smoking Assessment and Cessation Coincident With Spine-Related Therapies | Registry |
NPA19 | Body Mass Assessment and Follow-up Coincident With Spine-Related Therapies | Registry |
NPA6 | Spine-Related Procedure Site Infection | Registry |
RCOIR1 | CKD 3-5 Patients Seen at the Recommended Frequency Levels | Registry |
RCOIR10 | Upper Extremity Edema Improvement | Registry |
RCOIR12 | Tunneled Hemodialysis Catheter Success | Registry |
RCOIR3 | CKD 3-5 Patients with a Urine ACR or Urine PCR Lab Test | Registry |
RCOIR4 | CKD 4-5 Patients with Transplant Referral | Registry |
RCOIR5 | End Stage Renal Disease (ESRD) Initiation of Home Dialysis or Self-Care | Registry |
RCOIR7 | Improved Access Site Bleeding | Registry |
RPAQIR13 | Rate of Timely Documentation Transmission to Dialysis Unit/Referring Physician | Registry |
RPAQIR14 | Arteriovenous Graft Thrombectomy Success Rate | Registry |
RPAQIR15 | Arteriovenous Fistulae Thrombectomy Success Rate | Registry |
RPAQIR1 | Angiotensin Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy | Registry |
RPAQIR16 | Peritoneal Dialysis Catheter Success Rate | Registry |
RPAQIR17 | Peritoneal Dialysis Catheter Exit Site Infection Rate | Registry |
RPAQIR18 | Advance Directives Completed | Registry |
RPAQIR4 | Arteriovenous Fistula Rate | Registry |
RPAQIR5 | Transplant Referral | Registry |
RPAQIR9 | Advance Care Planning (Pediatric Kidney Disease) | Registry |
ACR7 | Gout: Serum Urate Target | Registry |
ARCO16 | Dyspnea or Heart Failure: Use of BNP or NT- pro BNP screening | Registry |
ARCO17 | Heart Failure: Use of Aldosterone Antagonists and Diuretics for Symptom Control | Registry |
ARCO18 | Heart Failure: Counseling on Self-care, Including Monitoring Blood Pressure, Weight, Sodium Intake, and Physical Activity | Registry |
NJIISMD1 | Critical Result: Pulmonary Embolism | Registry |
NJIISMD11 | Critical Result: New Deep Venous Thrombosis (DVT) | Registry |
NJIISMD17 | Result Requiring Follow Up Protocol | Registry |
NJIISMD19 | Critical Result: Cord Compression | Registry |
NJIISMD2 | Critical Result: Intracranial Hemorrhage | Registry |
NJIISMD20 | Critical Result: CTA of GI bleed | Registry |
NJIISMD21 | Critical Result: Positive nuclear bleeding scan | Registry |
NJIISMD22 | Critical Result: Acute Ocular injury | Registry |
NJIISMD3 | Critical Result: Aortic Dissection | Registry |
NJIISMD8 | Critical Result: Occlusive Intracranial Stroke | Registry |
NJIISMD9 | Critical Result: Placental abruption | Registry |
SMD23 | Urgent Result: Breast Specimen Radiography | Registry |
SMD24 | Critical Result: Testicular Torsion | Registry |
SMD25 | Critical Result: Subdural hematoma | Registry |
SMD26 | GI Radiography Result Notification
-Critical Result: Bowel Obstruction
-Critical Result: Sigmoid Volvulus
-Critical Result: Pneumoperitoneum | Registry |
SMD27 | Chest Imaging Result Notification:
-Critical Result: Pneumothorax
-Critical Result: Tension Pneumothorax
-Follow Up Result: Suspicious Lung Nodule | Registry |
SMD28 | Musculoskeletal Radiology Result Notification:
-Critical Result: C-Spine fracture
-Critical Result: Rib fracture
-Urgent Result: Osteomyelitis
-Urgent Result: Meniscal tear | Registry |
SMD29 | Incidental Finding Closed Loop Work Up Rate | Registry |
SMD30 | Aortic Aneurism Result Notification | Registry |
SMD31 | Ectopic Pregnancy Critical Results
-Critical Result: Ruptured Ectopic Pregnancy
-Critical Result: Ectopic Pregnancy | Registry |
SMD32 | Pathology Peer Review Duration (composite measure)
Strata:
-Breast cancer
-Lung cancer
-Melanoma
-Colorectal cancer | Registry |
SMD33 | Radiology Peer Review Duration (composite measure)
Strata:
-Pneumonia
-Pulmonary nodule
-Pulmonary embolism
-Stroke
-Intracranial hemorrhage | Registry |
SMD34 | Image Guided Lung Biopsy Complication Rate | Registry |
SMD35 | Thyroid biopsy - percentage of non-diagnostic samples | Registry |
ACS18 | Patient Frailty Evaluation | Registry |
ACS23 | Unplanned Hospital Readmission within 30 Days of Principal Procedure | Registry |
SCG05 | Improvement in Quality of Life from Partial Foot, Prosthetics | Registry |
SCG10 | Treatment and Management Outcomes of Acute Wounds and/or Ulcers | Registry |
SCG2 | Outcome Assessment for Patients Prescribed Ankle Orthosis for Ambulation and Functional Improvement | Registry |
SCG3 | Outcome Assessment for Patients Prescribed Foot Orthosis for Ambulation and Functional Improvement | Registry |
SCG8 | Pre-surgical screening for depression | Registry |
SCG9 | Avoidance of Inappropriate Emergency Department Use | Registry |
SMX10 | Prevalence and Severity of High Blood Pressure Among Children (SoDH) - Blood Pressure screening for children 1-13 years of age and 14 - 19 years of age | Registry |
SMX11 | Screening for Risk Factors for Adult Cardiovascular Disease in Children (SoDH) - Dyslipidemia screening for children ages 9 -11 and post-puberty ages 17-21 | Registry |
SPINETRACK5 | Percent of patients meeting SCB thresholds for leg or arm pain | Registry |
STS1 | Prolonged Length of Stay Following Coronary Artery Bypass Grafting | Registry |
STS11 | Lobectomy - Air Leak Greater than 5 Days | Registry |
STS3 | Prolonged Length of Stay for Coronary Artery Bypass Grafting (CABG) + Valve Replacement | Registry |
STS5 | Prolonged Length of Stay following Valve Surgery | Registry |
STS7 | Patient Centered Surgical Risk Assessment and Communication for Cardiac Surgery | Registry |
STS8 | Operative Mortality for Esophageal Resection | Registry |
ACS16 | Preventative Care and Screening: Tobacco Screening and Cessation Intervention | Registry |
ACS20 | Optimal Postoperative Communication Plan and Patient Care Coordination Composite | Registry |
ACS21 | Post-Acute Recovery Composite | Registry |
ACS22 | Unplanned Reoperation within the 30 Day Postoperative Period | Registry |
ACS24 | Surgical Phases of Care Patient-Reported Outcome Composite Measure | Registry |
ACS25 | Surgical Site Infection (SSI) | Registry |
NIPM18 | CHANGE IN PATIENT REPORTED QUALITY OF LIFE FOLLOWING EPIDURAL LYSIS OF ADHESIONS | Registry |
NIPM19 | CHANGE IN PATIENT REPORTED QUALITY OF LIFE AND FUNCTIONAL STATUS FOLLOWING MEDIAL BRANCH RADIOFREQUENCY ABLATION | Registry |
NIPM20 | CHANGE IN PATIENT REPORTED PAIN AND FUNCTIONAL STATUS FOLLOWING SPINAL CORD STIMULATOR IMPLANTATION | Registry |
NIPM21 | REDUCTION IN PATIENT REPORTED PAIN FOLLOWING MEDIAL BRANCH RADIOFREQUENCY ABLATION | Registry |
NIPM22 | CHANGE IN PATIENT REPORTED QUALITY OF LIFE FOLLOWING EPIDURAL CORTICOSTEROID INJECTION | Registry |
NIPM23 | CHANGE IN PATIENT REPORTED QUALITY OF LIFE FOLLOWING MAJOR JOINT CORTICOSTEROID INJECTION | Registry |
CDR2 | Diabetic Foot Ulcer (DFU) Healing or Closure | Registry |
CDR3 | Plan of Care Creation for Diabetic Foot Ulcer (DFU) and Venous Leg Ulcer (VLU) not Achieving 30% Closure at 4 Weeks after undergoing treatment with CTP | Registry |
CDR5 | Adequate Compression at each visit for Patients with VLUs | Registry |
CDR6 | Venous Leg Ulcer (VLU) outcome measure: Healing or Closure | Registry |
CDR8 | Appropriate Use of hyperbaric oxygen therapy for patients with diabetic foot ulcers | Registry |
CDR9 | Appropriate Use of Cellular and/or Tissue Based Product (CTP) in diabetic foot ulcers (DFUs) or venous leg ulcer (VLUs) among patients 18 years or older | Registry |
USWR16 | Major Amputation in Wagner 3, 4, or 5 Diabetic Foot Ulcers (DFUs) Treated with HBOT | Registry |
USWR22 | Patient Reported Nutritional Assessment in Patients with Wounds and Ulcers | Registry |
USWR23 | Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential | Registry |
USWR24 | Patient Reported Experience of Care: Wound Outcome | Registry |
USWR25 | Non-lower extremity Pressure Ulcer* (PU) Healing or Closure | Registry |
USWR26 | Patient Reported Outcome of late effects of radiation symptoms following treatment with Hyperbaric Oxygen Therapy (HBOT) | Registry |
UREQA1 | Ankylosing Spondylitis: Controlled Disease | Registry |
UREQA2 | Ankylosing Spondylitis: Appropriate Pharmacologic Therapy | Registry |
UREQA3 | Controlled Gout for Patients on Urate-Lowering Pharmacologic Therapy | Registry |
UREQA4 | Folic or Folinic Acid Therapy for Patients Treated with Methotrexate | Registry |
UREQA6 | Psoriatic Arthritis (PsA): Close Monitoring for Newly Diagnosed Patients | Registry |
VCMAHEMR1 | Advance Care planning: Electronic submission of new POLST/MOLST/POST/MOST ("orders for life-sustaining treatment" or "orders for scope of treatment") into an eRegistry or patient medical record. | Registry |